Laurus Labs Limited (BOM:540222)
1,361.60
-19.55 (-1.42%)
At close: May 29, 2026
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 735.28 billion as of May 29, 2026. Its market cap has increased by 131.58% in one year.
Market Cap
735.28B
Enterprise Value
760.65B
Revenue
68.13B
Ranking
n/a
PE Ratio
82.73
Stock Price
1,361.60
Market Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 735.28B, an increase of 1,449.99%. That is a compound annual growth rate of 33.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 735.28B | 22.92% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 215.02B |
| Shilpa Medicare | 96.26B |
| Suven Life Sciences | 70.39B |
| Gujarat Themis Biosyn | 47.24B |
| IOL Chemicals and Pharmaceuticals | 38.55B |
| Sai Parenteral's | 21.42B |
| NGL Fine-Chem | 16.68B |
| Bajaj HealthCare | 10.31B |